Pancreatic Hormones and Glucose Metabolism

Pancreatic Hormones and Glucose Metabolism

Pancreatic Hormones and Glucose Metabolism

On this page

Pancreatic Islet Hormones - Islet's Endocrine Symphony

Endocrine pancreas: Islets of Langerhans. 📌 Cells: Beta (Insulin), Alpha (Glucagon), Delta (Somatostatin).

  • α-cells (Glucagon): ↑ Blood glucose (glycogenolysis, gluconeogenesis).
  • β-cells (Insulin, Amylin): ~70% of islet cells. Insulin: ↓ Blood glucose. Amylin: ↓ Glucagon.
    • Proinsulin → Insulin + C-peptide (equimolar).
  • δ-cells (Somatostatin): Paracrine inhibition of insulin & glucagon.
  • PP-cells (Pancreatic Polypeptide): Regulates pancreatic exocrine/endocrine functions. Islet of Langerhans cell types and hormones

⭐ C-peptide measurement is crucial for assessing endogenous insulin production, especially in diabetic patients on insulin therapy.

Insulin Physiology - Insulin: The Key Master

  • Structure: Peptide hormone; A (21 amino acids) & B (30 amino acids) chains, linked by disulfide bonds.
  • Synthesis: Pancreatic β-cells: Preproinsulin → Proinsulin (Golgi) → Insulin + C-peptide (secretory granules).
    • 📌 C-peptide: Equimolar secretion; reliable marker of endogenous insulin production.
  • Secretion Stimuli:
    • Primary: ↑ Blood glucose (via GLUT2 on β-cells → ↑ATP → KATP channel closure → Ca2+ influx → exocytosis).
    • Others: Amino acids (arginine, leucine), incretins (GLP-1, GIP), vagal stimulation (ACh), β2-agonists.
  • Secretion Inhibitors: Somatostatin, sympathetic stimulation (α2-adrenergic), diazoxide, propranolol.
  • Receptor: Tyrosine kinase receptor (2α, 2β subunits). Binding → autophosphorylation → IRS activation → PI3K & MAPK pathways.
  • Key Actions (Anabolic Hormone):
    • ↓ Blood glucose: ↑ GLUT4 translocation (muscle, adipose), ↑ glycogenesis, ↓ gluconeogenesis, ↓ glycogenolysis.
    • ↑ Lipogenesis (activates LPL, acetyl-CoA carboxylase), ↓ lipolysis (inhibits HSL).
    • ↑ Protein synthesis, ↓ proteolysis.
    • ↑ Cellular K+ uptake (stimulates Na+/K+-ATPase).

Glucose-Stimulated Insulin Secretion from Beta Cell

⭐ Insulin promotes K+ entry into cells by stimulating Na+/K+-ATPase activity; this is crucial in managing DKA, as insulin therapy can cause hypokalemia.

Glucagon Physiology - Glucagon: Glucose Lifeguard

  • Source: Peptide, pancreatic α-cells.
  • Function: ↑ Blood glucose; counter-regulatory to insulin. (📌 Mnemonic: Glucagon when "Glucose-is-GONE")
  • Stimuli:
    • Hypoglycemia (primary)
    • Amino acids (arginine, alanine; post-protein meal)
    • Sympathetic (β-adrenergic), Cortisol, CCK
  • Inhibitors:
    • Hyperglycemia, Insulin
    • Somatostatin, GLP-1, fatty acids
  • Mechanism (Liver): Gs-coupled receptor → ↑adenylyl cyclase → ↑cAMP → PKA.
  • Hepatic Effects:
    • ↑ Glycogenolysis (major, rapid glucose output)
    • ↑ Gluconeogenesis (sustained glucose production)
    • ↑ Ketogenesis (from fatty acid breakdown)
    • ↑ Urea cycle activity
  • Adipose Tissue: ↑ Lipolysis (HSL activation, generally minor in humans).

⭐ Glucagon's primary, most rapid effect is stimulating hepatic glycogenolysis to elevate blood glucose.

Glucose Regulation & Imbalance - Sweet Balance & Chaos

  • Core Balance: Maintained by insulin (↓ blood glucose) & glucagon (↑ blood glucose).
    • Normal Fasting Glucose: 70-100 mg/dL.
    • Post-Prandial (2hr): <140 mg/dL.
  • Insulin (Anabolic): From β-cells.
    • ↑ Glucose uptake (GLUT4: muscle, adipose).
    • ↑ Glycogenesis, ↑ Lipogenesis.
    • ↓ Gluconeogenesis, ↓ Glycogenolysis.
  • Glucagon (Catabolic): From α-cells.
    • ↑ Glycogenolysis (liver).
    • ↑ Gluconeogenesis (liver).
  • Flow of Control:
  • Imbalance States:
    • Diabetes Mellitus (DM): Persistent hyperglycemia.
      • Diagnosis: FPG ≥126 mg/dL; PPG (2hr) ≥200 mg/dL; HbA1c ≥6.5%.
    • Hypoglycemia: Blood glucose <70 mg/dL.
      • Whipple's Triad: Symptoms + Low BG + Relief with glucose.

⭐ In Diabetic Ketoacidosis (DKA), total body potassium is depleted despite potential normal/high serum K+ due to extracellular shift from acidosis & insulinopenia.

High‑Yield Points - ⚡ Biggest Takeaways

  • Insulin (β-cells): anabolic, ↑ glucose uptake via GLUT4 (muscle/adipose). Deficiency → DM Type 1.
  • Glucagon (α-cells): catabolic, ↑ glycogenolysis & gluconeogenesis.
  • Somatostatin (δ-cells): inhibits insulin & glucagon secretion.
  • GLUT2: insulin-independent (β-cells, liver); GLUT4: insulin-dependent (muscle, adipose).
  • HbA1c: reflects 2-3 month glucose control; target <7%.
  • DKA (T1DM): hyperglycemia, ketosis, acidosis.
  • HHS (T2DM): severe hyperglycemia, hyperosmolality, minimal/no ketosis_._

Practice Questions: Pancreatic Hormones and Glucose Metabolism

Test your understanding with these related questions

Increased insulin is characterized by all of the following, except:

1 of 5

Flashcards: Pancreatic Hormones and Glucose Metabolism

1/10

Glucagon-like peptide-1 (GLP-1) stimulates _____ secretion and inhibits glucagon secretion

TAP TO REVEAL ANSWER

Glucagon-like peptide-1 (GLP-1) stimulates _____ secretion and inhibits glucagon secretion

insulin

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial